Stay updated on Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Sign up to get notified when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.

Latest updates to the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2, indicating that the page has been updated. This update does not alter the study details or core information presented.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page’s revision tag has been updated from v3.6.0 to v3.6.2, signaling a minor platform update. This change does not affect study details or how users interact with the page.SummaryDifference0.1%

- Check30 days agoChange DetectedRecruitment status updated to no longer recruit participants, indicating the study has been terminated. The page also gained new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a site revision tag (Revision: v3.6.0), with the Intervention/Treatment heading added as part of the update.SummaryDifference0.6%

- Check38 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating an updated page version rather than a change to the trial’s information.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous revision tag. This indicates a minor update to the page version.SummaryDifference0.1%

- Check80 days agoChange DetectedClinicalTrials.gov updated the displayed site revision from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

Stay in the know with updates to Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.